CAPOX
Showing 1 - 25 of 149
Low Rectal Cancer Trial in Hanzhou (Modified short-course radiotherapy, PD-1 antibody, Capecitabine)
Not yet recruiting
- Low Rectal Cancer
- Modified short-course radiotherapy
- +3 more
-
Hanzhou, Zhejiang, ChinaSir Run Run Shao hospital
Jul 31, 2023
Rectal Cancer Trial in Fuzhou (radiation, drug, procedure)
Not yet recruiting
- Rectal Cancer
- split-course hypofraction radiotherapy
- +3 more
-
Fuzhou, Fujian, ChinaPan Chi
Jul 23, 2023
MSI-H Colorectal Cancer, Tislelizumab, Oxaliplatin Trial (Tislelizumab)
Not yet recruiting
- MSI-H Colorectal Cancer
- +3 more
- (no location specified)
Apr 23, 2023
Advanced Solid Tumors Trial (ASKB589 Injection)
Not yet recruiting
- Advanced Solid Tumors
- ASKB589 Injection
- (no location specified)
Nov 21, 2022
Biliary Cancer, Bile Duct Cancer, Cancer of the Bile Duct Trial run by the National Cancer Institute (NCI) (oxaliplatin,
Not yet recruiting
- Biliary Cancer
- +2 more
- oxaliplatin
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
May 13, 2023
Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Beijing (CS1001 mAb, CS1001 , Oxaliplatin)
Active, not recruiting
- Gastric Adenocarcinoma
- Gastroesophageal Junction Adenocarcinoma
- CS1001 monoclonal antibody
- +3 more
-
Beijing, ChinaBeijing Cancer Hospital
Sep 27, 2022
Gastric Cancer, Gastroesophageal-junction Cancer, Advanced Cancer Trial (TST001, CapOx or mFOLFOX6 and NIVO or (Substudy)
Not yet recruiting
- Gastric Cancer
- +2 more
- TST001, CapOx or mFOLFOX6 and NIVO or (Substudy) TST001, Oxaliplatin and capecitabine or 5-fluorouracil (5-FU)
- Placebo CapOx or mFOLFOX6 and NIVO or (Substudy) Placebo, Oxaliplatin and capecitabine or 5-fluorouracil (5-FU)
- (no location specified)
Oct 16, 2023
Colorectal Cancer Liver Metastases Trial (CapOx(Capecitabine+ Oxaliplatin), Bevacizumab, Nivolumab)
Not yet recruiting
- Colorectal Cancer Liver Metastases
- CapOx(Capecitabine+ Oxaliplatin)
- +2 more
- (no location specified)
Oct 18, 2022
Advanced Gastroesophageal Adenocarcinoma, First-line Therapy, PDL1 CPS < 5 Trial (CAPOX combined with bevacizumab and
Not yet recruiting
- Advanced Gastroesophageal Adenocarcinoma
- +2 more
- CAPOX combined with bevacizumab and Tislelizumab
- (no location specified)
Mar 17, 2022
Locally Advanced Rectal Cancer Trial in Japan (SCRT, CAPOX, CAPOXIRI)
Recruiting
- Locally Advanced Rectal Cancer
- SCRT
- +2 more
-
Chiba, Japan
- +21 more
Dec 9, 2022
ADjuvant chemotherAPy After Curative Intent resecTion of
Recruiting
- Ampullary Adenocarcinoma
- Folfirinox
- Capox
-
Brescia, BS, ItalyFondazione Poliambulanza
Oct 3, 2023
Rectal Cancer Trial in Osaka (radiation, drug, procedure)
Recruiting
- Rectal Cancer
- Radiation
- +2 more
-
Osaka, Japan
- +1 more
Jul 1, 2023
Locally Advanced Colon Cancer Trial (Serplulimab, short-term radiotherapy, Oxaliplatin)
Not yet recruiting
- Locally Advanced Colon Cancer
- Serplulimab
- +3 more
- (no location specified)
Feb 16, 2023
Colon Cancer Trial (mFOLFIRINOX-FOLFIRI intensified chemo, FOLFOX or CAPOX adjuvant chemo)
Not yet recruiting
- Colon Cancer
- mFOLFIRINOX-FOLFIRI intensified chemotherapy
- FOLFOX or CAPOX adjuvant chemotherapy
- (no location specified)
Sep 6, 2022
Rectal Cancer, Neoadjuvant Chemo Trial in Wuxi, Chengdu, Kunming (Capox chemo)
Recruiting
- Rectal Cancer
- Neoadjuvant Chemotherapy
- Capox chemotherapy
-
Wuxi, Jiangsu, China
- +3 more
Mar 16, 2022
Stage III Colon Cancer Trial in Pittsburgh (Signatera test, mFOLFOX6 3-6 month, CAPOX 3 month)
Recruiting
- Stage III Colon Cancer
- Signatera test
- +5 more
-
Pittsburgh, PennsylvaniaNRG Oncology - Pittsburgh Center
Mar 30, 2022
Gallbladder Cancer Trial in Varanasi (Everolimus 10 mg, Standard of care)
Recruiting
- Gallbladder Cancer
- Everolimus 10 mg
- Standard of care
-
Varanasi, UP, IndiaBanaras Hindu University
Apr 18, 2023
Colorectal Cancer, Liver Metastases, Liver Metastasis Colon Cancer Trial in Amsterdam (Neoadjuvant systemic therapy (CAPOX+/-B
Recruiting
- Colorectal Cancer
- +5 more
- Neoadjuvant systemic therapy (CAPOX+/-B FOLFOX+/-B FOLFIRI+/-B)
- Repeat local treatment
-
Amsterdam, NetherlandsAmsterdam UMC
May 5, 2023
Gastric Cancer, Peritoneal Metastases Trial in Rotterdam (Irinotecan, CAPOX)
Recruiting
- Gastric Cancer
- Peritoneal Metastases
- Irinotecan
- CAPOX
-
Rotterdam, Zuid-Holland, NetherlandsErasmus MC
Jun 15, 2022
Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma Cancer, Locally Advanced Unresectable Gastric
Available
- Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma Cancer
- +3 more
-
Morristown, New JerseyAMG Hematology/Oncology
Sep 15, 2023
Locally Advanced Colorectal Cancer Trial (Capecitabine, Oxaliplatin, Bevacizumab)
Not yet recruiting
- Locally Advanced Colorectal Cancer
- Capecitabine
- +3 more
- (no location specified)
Oct 18, 2022
Locally-advanced Rectal Cancer Trial in Lyon, Villejuif (mFOLFIRINOX, Pelvic radiotherapy LCRT, Capecitabine)
Not yet recruiting
- Locally-advanced Rectal Cancer
- mFOLFIRINOX
- +6 more
-
Lyon, Rhöne, France
- +1 more
Jun 12, 2023
Gastric or Gastroesophageal Junction Cancer Trial in Beijing (SHR-1701?CAPOX/FOLFOX, Placebo?CAPOX/FOLFOX)
Recruiting
- Gastric or Gastroesophageal Junction Cancer
- SHR-1701、CAPOX/FOLFOX
- Placebo、CAPOX/FOLFOX
-
Beijing, Beijing, ChinaBeijing Cancer Hospital
Dec 14, 2021
Locally Advanced Rectal Carcinoma Trial in Cairo (short course radiation therapy followed by 6 cycles of CAPOX then surgery)
Completed
- Locally Advanced Rectal Carcinoma
- short course radiation therapy followed by 6 cycles of CAPOX then surgery
-
Cairo, الجيزة, EgyptNational Cancer Institute
Nov 11, 2022
Biliary Tract Tumors, Cholangiocarcinoma, Bile Duct Cancer Trial run by the NCI (Pembrolizumab (MK-3475), Oxaliplatin,
Completed
- Biliary Tract Neoplasms
- +4 more
- Pembrolizumab (MK-3475)
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Dec 1, 2021